Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces that the U.S. Food and ...

Back in 2021, Amgen picked up the phase 3-ready candidate in a $1.9 billion acquisition of Five Prime Therapeutics. The ...

cancer with FGFR2b overexpression and who are non-HER2 positive. FGFR2b overexpression was defined as 2+/3+ staining in ≥10% of tumor cells by centrally performed immunohistochemistry (IHC) testing.

The study showed a >95% technical success rate when used with brush biopsy samples, a less invasive alternative to forceps ...

The 27-year-old made jaws drop in her tiny white two-piece that contrasted with her bronzed complexion.

"He'd seen the same demon, but he didn't tell me until recently because he didn't want to scare me any more than I already ...

It was another very strong month for Broadway, with three of the four weeks exceeding $40 million in total gross. This has been the strongest start to the Broadway season gross wise through the first ...